Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn's disease patients stopping infliximab

被引：0

作者：

Pierre, N. ^{[1
]}

Huynh-Thu, V. A. ^{[2
]}

Baiwir, D. ^{[3
]}

Mazzucchelli, G. ^{[4
]}

Fleron, M. ^{[3
]}

Trzpiot, L. ^{[4
]}

Eppe, G. ^{[4
]}

Laharie, D. ^{[5
]}

Satsangi, J. ^{[6
]}

Colombel, J. F. ^{[7
]}

Hertervig, E. ^{[8
]}

Meuwis, M. A. ^{[1
]}

Louis, E. ^{[9
]}

机构：

[1] Univ Liege, Lab Translat Gastroenterol, Liege, Belgium

[2] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium

[3] Univ Liege, GIGA Prote Facil, Liege, Belgium

[4] Univ Liege, Lab Mass Spectrometry, Liege, Belgium

[5] Ctr Hosp Univ Bordeaux, Serv Hepatogastroenterol & Oncol Digest, Bordeaux, France

[6] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England

[7] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA

[8] Skane Univ Hosp, Dept Gastroenterol, Lund, Sweden

[9] Liege Univ Hosp, Hepatogastroenterol & Digest Oncol Dept, Liege, Belgium

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OP02

引用

页码：I3 / I6

页数：5

共 50 条

[31] Long-term infliximab treatment in a patient with fistualizing Crohn's disease
Wisniewska-Jarosinska, Maria
Wichan, Pawel
Chojnacki, Jan
PRZEGLAD GASTROENTEROLOGICZNY, 2009, 4 (05): : 277 - 281
[32] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
Baert, F
Noman, M
Vermeire, S
Van Assche, G
D'Haens, G
Carbonez, A
Rutgeerts, P
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 601 - 608
[33] Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults With Crohn's Disease
Bhattacharya, Abhik
Travis, Daniel
Osterman, Mark T.
Lewis, James D.
Rao, Bhavana Bhagya
Lee, Helen
Lichtenstein, Gary R.
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (01) : 66 - 73
[34] Impact of Infliximab on Short-Term Postoperative Outcomes in Patients With Crohn's Disease Undergoing Ileocolic Resection
Althumairi, Azah
Efron, Jonathan E.
Truta, Brindusa
Canner, Joseph K.
Gearhart, Susan
Wick, Elizabeth
Fang, Sandy H.
Safar, Bashar
GASTROENTEROLOGY, 2015, 148 (04) : S232 - S232
[35] Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice
Cadahia, V
García-Carbonero, A
Vivas, S
Fuentes, D
Niño, P
Rebollo, P
Rodrigo, L
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 369 - 374
[36] Evaluation and Long-Term Benefit of Deep Remission in Crohn's Disease Patients Treated With Infliximab
de Chambrun, Guillaume Pineton
Libier, Louise
Collins, Michael
Nachury, Maria
Gower-Rousseau, Corinne
Zerbib, Philippe
Cortot, Antoine
Colombel, Jean-Frederic
Desreumaux, Pierre
Blanc, Pierre
GASTROENTEROLOGY, 2016, 150 (04) : S810 - S811
[37] Evaluation and Long-Term Benefit of Mucosal Healing in Crohn's Disease Patients Treated With Infliximab
Libier, Louise
Collins, Michael
Koriche, Dine
Nachury, Maria
Gower-Rousseau, Corinne
Zerbib, Philippe
Cortot, Antoine
Colombel, Jean-Frederic
Desreumaux, Pierre
de Chambrun, Guillaume Pineton
GASTROENTEROLOGY, 2015, 148 (04) : S450 - S450
[38] Evaluation and long-term benefit of mucosal healing in Crohn's disease patients treated with infliximab
Libier, L.
Collins, M.
Koriche, D.
Nachury, M.
Gower-Rousseau, C.
Zerbib, P.
Cortot, A.
Colombel, J. -F.
Desreumaux, P.
de Chambrun, G. Pineton
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S292 - S292
[39] Short and long term safety of remicade (infliximab) in Crohn's disease and rheumatoid arthritis
Louis, E
Rutgeerts, P
Westhovens, R
De Vos, M
Veys, P
Van Gossum, A
Malaise, M
Pescatore, P
Fiasse, R
Pelckmans, P
Reynaert, H
Van Den Bosch, F
D'Haens, G
Belaiche, J
Durez, P
GASTROENTEROLOGY, 2002, 122 (04) : A614 - A614
[40] Loss of Response to Long-Term Infliximab Therapy in Children with Crohn's Disease
Gouldthorpe, Oliver
Catto-Smith, Anthony G.
Alex, George
Simpson, Di
PHARMACEUTICALS, 2013, 6 (10): : 1322 - 1334

← 1 2 3 4 5 →